A landmark Phase 2 study will test smoked, high-THC flower versus placebo in 320 veteran participants with moderate to severe PTSD. Here’s what’s being studied and why it matters for DMV patients.

Gov. Maura Healey files a budget provision allowing veterans with qualifying VA diagnoses to join state medical programs without secondary physician sign-offs.

An executive order in Puerto Rico directs health officials to build a pilot program for ibogaine, psilocybin, and MDMA research, with veterans prioritized for potential clinical trial access.

Resilient Pharmaceuticals submits a renewed application for MDMA-assisted PTSD therapy, seeking FDA approval without a fresh Phase 3 trial.